Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline

NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018

Richard T Hoppe et al. J Natl Compr Canc Netw. 2018 Mar.

Abstract

The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN Guidelines Panel meets at least annually to review comments from reviewers within the NCCN Member Institutions, examine relevant data, and reevaluate and update the recommendations. These NCCN Guidelines Insights summarize recent updates centered on treatment considerations for relapsed/refractory classic HL.

PubMed Disclaimer

Similar articles

  • Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
    Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, Benitez CM, Bierman PJ, Boughan KM, Dabaja B, Gordon LI, Hernandez-Ilizaliturri FJ, Herrera AF, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Lynch RC, Maddocks K, McConathy J, McKinney M, Metzger M, Morgan D, Mulroney C, Rabinovitch R, Rosenspire KC, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N. Hoppe RT, et al. J Natl Compr Canc Netw. 2020 Jun;18(6):755-781. doi: 10.6004/jnccn.2020.0026. J Natl Compr Canc Netw. 2020. PMID: 32502987
  • Pediatric Hodgkin Lymphoma, Version 3.2021.
    Flerlage JE, Hiniker SM, Armenian S, Benya EC, Bobbey AJ, Chang V, Cooper S, Coulter DW, Cuglievan B, Hoppe BS, Isenalumhe L, Kelly K, Kersun L, Lamble AJ, Larrier NA, Magee J, Oduro K, Pacheco M, Price AP, Roberts KB, Smith CM, Sohani AR, Trovillion EM, Walling E, Xavier AC, Burns JL, Campbell M. Flerlage JE, et al. J Natl Compr Canc Netw. 2021 Jun 30;19(6):733-754. doi: 10.6004/jnccn.2021.0027. J Natl Compr Canc Netw. 2021. PMID: 34214968
  • NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022.
    Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, Benitez CM, Chen W, Dabaja B, Daly ME, Gordon LI, Hansen N, Herrera AF, Hochberg EP, Johnston PB, Kaminski MS, Kelsey CR, Kenkre VP, Khan N, Lynch RC, Maddocks K, McConathy J, Metzger M, Morgan D, Mulroney C, Pullarkat ST, Rabinovitch R, Rosenspire KC, Seropian S, Tao R, Torka P, Winter JN, Yahalom J, Yang JC, Burns JL, Campbell M, Sundar H. Hoppe RT, et al. J Natl Compr Canc Netw. 2022 Apr;20(4):322-334. doi: 10.6004/jnccn.2022.0021. J Natl Compr Canc Netw. 2022. PMID: 35390768
  • Immunotherapy for the treatment of Hodgkin lymphoma.
    Donato EM, Fernández-Zarzoso M, De La Rubia J. Donato EM, et al. Expert Rev Hematol. 2017 May;10(5):417-423. doi: 10.1080/17474086.2017.1313701. Epub 2017 Apr 12. Expert Rev Hematol. 2017. PMID: 28359170 Review.
  • Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents.
    Giulino-Roth L, Keller FG, Hodgson DC, Kelly KM. Giulino-Roth L, et al. Br J Haematol. 2015 Jun;169(5):647-60. doi: 10.1111/bjh.13372. Epub 2015 Mar 30. Br J Haematol. 2015. PMID: 25824371 Review.
See all similar articles

Cited by

See all "Cited by" articles

Publication types

LinkOut - more resources